7-15-10 The Small Cap Market Update from Express IR

With congressional and senate support, President Obama is expected to let the Bush Tax cuts expire at the end of 2010. Estimates on the tax increase to U.S. citizens’ range from $500 billion to $1 trillion. While the additional revenue is one way to help pay for the massive federal spending increases, the taxes on businesses and investors will be very significant.

In 2003, capital gains tax rates were reduced from 20 percent to 15 percent and from 10 percent to 5 percent depending on individual tax brackets. Surprising to some economists, capital gains revenues more than doubled to $103 billion according to the CBO, rather than projected 36 percent increase.

Lower capital gains taxes encourage investing which increases funding for research and development, expansion, and start up. Such investment is vital for long-term economic growth. And because investors are tax-sensitive, high capital gains tax rates are not only bad economic policy, but also bad budget policy.

The unintended consequences from a shallow campaign promise, probably more designed to pander to one group or another is a borderline disastrous idea. A good leader evaluates the landscape, anticipates environmental changes, and charts an appropriate course of action.

Tax revenues are a function of tax rates and tax base. History has demonstrated time and time again that tax revenue grows greatest when the economy expands. More importantly, there is an inverse relationship between tax base and tax rates. Since the early 1950’s the highest marginal income tax rate has dropped from 92 percent to 35 percent, and tax revenues have grown in inflation-adjusted terms while remaining constant as a percent of GDP. Go figure.

Today’s Markets

The streak is over as stocks slipped the Dow Jones industrial average lost 64 points, or 0.6%, and the market broke its seven-day winning streak. The Nasdaq composite lost 14 points, or 0.6%.

On Wednesday, the Federal Reserve lowered its forecast for GDP growth this year. On Thursday, a report showed that weekly jobless claims fell to a two-year low — but continuing claims, a measure of long-term joblessness, rose. Weak reports on manufacturing in the New York and Philadelphia regions added to the jitters.

On Thursday afternoon, the financial reform bill cleared a major obstacle in the Senate, moving it closer to safe passage and onto the desk of President Obama to be signed into law.

The legislation is designed to limit big banks, protect consumers and prevent the future reoccurrence of financial crises like the one that hit in 2008.

Today’s Top Performers on the OTCBB

Company Symbol Last Chg %Chg Open High Low Vol
Liberty Star Urani LBSR 0.0264 0.0242 1,100.00% 0.0245 0.0299 0.0235 4.73 m
Cistera Networks I CNWT 0.51 0.46 920.00% 0.51 0.51 0.51 1,000
JinZangHuang Tibet JZHG 1.00 0.75 300.00% 1.00 1.00 1.00 100
Milwaukee Iron Are MWKI 0.012 0.008 200.00% 0.0041 0.012 0.0041 30.23 k
Shelron Group Inc. SRNG 0.0249 0.0158 173.63% 0.027 0.027 0.0249 5.73 k
Vapor Corp. VPCO 0.40 0.25 166.67% 0.40 0.40 0.40 250
Mirenco Inc. MREO 0.10 0.06 150.00% 0.10 0.10 0.10 2 k
International Card ICRD 0.015 0.009 150.00% 0.006 0.015 0.006 11.5 k
Standard Gold Inc. SDGR 0.60 0.30 100.00% 0.60 0.60 0.60 2.1 k
Aultra Gold Inc. AGDI 0.01 0.005 100.00% 0.008 0.01 0.008 4 k

Thursday’s Newsmakers:

mBeach Software Inc. Finalizes Acquisition of Skin Cancer Scanning Ltd.

Jul. 15, 2010 (GlobeNewswire)

TEL AVIV, Israel, July 15, 2010 (GLOBE NEWSWIRE) — mBeach Software Inc. (“MBHS”) MBHS announced today that it has finalized and closed the merger for the acquisition of Skin Cancer Scanning Ltd. (“SCS”). As a result of the acquisition, MBHS will hold 100% of SCS.

The former management of MBHS has been entirely replaced by the new management of SCS.

MBHS has filed several 8-k reports with the Securities and Exchange Commission pertaining to the transaction including a super 8-k. We invite the public to review them and obtain more information.

MBHS’s new CEO, Mr. Yossi Biderman, Col., stated, “We feel that the merger between MBHS and SCS will greatly increase shareholder value. We believe SCS is a very exciting company with strong potential to succeed in the global market for advanced technologies to better detect skin cancers.”

About SCS

Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the development and commercialization of a revolutionary and proprietary imaging system for the early detection and diagnosis of skin cancer.

Our product, SkinScan 650, is a non-invasive, point-of-care (in the doctor’s office) system to detect and identify different kinds of skin nevi, tumors, lesions and cancers. SkinScan 650 enables physicians to diagnose skin cancer at an earlier, more curable stage. This will reduce the number of biopsies, lower treatment costs, and improve quality of life.

For more information on SCS, visit www.scs-med.com.

Forward-Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of SCS’ products, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.

CONTACT:  
mBeach Software, Inc.
Mr. Yossi Biderman, CEO
011 972542060940
107 Hashmonaim Rd.  POB 20335
Tel Aviv 61202

Source: Globe Newswire (July 15, 2010 – 3:01 PM EDT)        
News by QuoteMedia

Express IR (XIR) is an electronic publication, and is for informational purposes only. The stocks profiled by XIR are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. XIR is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. For compensation and complete disclaimer click here.

Contact:

Ralph Sharp
rsharp@expressir.com

More About mBeach Software Inc. & Small Cap Stocks

Twitter Blogger Post AIM Technorati Favorites AOL Mail Yahoo Buzz Plaxo Pulse NewsVine Delicious Facebook Google Bookmarks Hotmail Netvibes Share LinkedIn Bebo Digg Fark Google Reader LiveJournal MySpace StumbleUpon Yahoo Bookmarks WordPress Yahoo Messenger Yahoo Mail Share/Bookmark

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!